Pathobiology of Lp(a) in calcific aortic valve disease

Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Marlys L. Koschinsky(Western University), Marie‐Chloé Boulanger(Institut universitaire de cardiologie et de pneumologie de Québec), Benoît J. Arsenault(Emory University), Yohan Bossé(Institut universitaire de cardiologie et de pneumologie de Québec)
Expert Review of Cardiovascular Therapy
August 17, 2017
10.1080/14779072.2017.1367286
Cited by 26

Related Papers

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
|JAMA|2012|800
A Proteomic Analysis of Arginine-methylated Protein Complexes
|Molecular & Cellular Proteomics|2003|358
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343
Comparison Between Transcatheter and Surgical Prosthetic Valve Implantation in Patients With Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction
|Circulation|2010|305